Symbol
|
XFGLTQ | RMBTGV | ZEOLTQ | BROBKB | RMBEFV | KQAPDU | ZNYLTQ | MBPQJB | BYDBKB | Z09N8Z | ABOESQ | RMBFDV | DGHCBL | ABRFSQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nom | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible with European Knock-In | Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Lock-In Barrier Reverse Convertible | Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Multi Defender Vonti | Barrier Reverse Convertible | Barrier Reverse Convertible |
Sous-jacent
|
Johnson & Johnson / Moderna Inc. / Pfizer Inc. | BioNTech SE / Moderna Inc. / Pfizer Inc. | BioNTech SE / Moderna Inc. | Johnson & Johnson / Moderna Inc. / Pfizer Inc. | Johnson & Johnson / Moderna Inc. / Pfizer Inc. | Johnson & Johnson / Moderna Inc. / Pfizer Inc. | Johnson & Johnson / Merck & Co. Inc. / Moderna Inc. / Pfizer Inc. | Eli Lilly & Co. / Moderna Inc. / Novo Nordisk AS (B) | BioNTech SE / Moderna Inc. | Amgen Inc. / Biogen Inc. / Moderna Inc. | Moderna Inc. / Novartis AG / Roche AG | Biogen Inc. / BioNTech SE / Moderna Inc. | Johnson & Johnson / Merck & Co. Inc. / Moderna Inc. | Eli Lilly & Co. / Moderna Inc. / Pfizer Inc. |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
16.09.2024 | 31.12.2024 | 15.05.2025 | 05.09.2025 | 24.06.2025 | 07.04.2025 | 15.07.2025 | 28.05.2025 | 17.09.2025 | 17.06.2025 | 01.07.2025 | 15.07.2025 | 12.01.2026 | 05.08.2025 |
Demande | 73,10 | 96,60 | 95,55 | 95,70 | 96,40 | 87,05 | 90,59 | 82,25 | 74,36 | 75,14 | 80,39 | 87,30 | 90,28 | 89,27 |
Offre | - | 97,40 | 96,35 | 96,50 | 97,20 | 88,05 | 91,39 | 82,75 | 99,50 | 92,40 | 81,19 | 88,30 | 91,08 | 90,07 |